IP Verse

Brand Murray Fuller competitive analysis

Explore patent oppositions filed by Brand Murray Fuller against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Feb 5, 2026

Patent Number	Title	Applicant	Opposition Date
EP3470400	Crystal Form Of Ozanimod, Crystal Form Of Hydrochloride Thereof, And Preparation Method Therefor	CRYSTAL PHARMACEUTICAL SUZHOU	Jan 2, 2026
EP3329965	Dosing Regimen Of Anti-Alpha4Beta7-Antibodies	MILLENNIUM PHARMACEUTICALS	Dec 17, 2025
EP4234033	Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab	F HOFFMANN LA ROCHE	Oct 23, 2025
EP3321270	Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-Olate	GILEAD SCIENCES	Sep 4, 2025
EP4176877	Methods Of Enhancing And/Or Stabilizing Cardiac Function In Patients With Fabry Disease	AMICUS THERAPEUTICS	Sep 4, 2025
EP4114390	Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla Gene	AMICUS THERAPEUTICS	Sep 3, 2025
EP3914247	Use Of Migalostat In Reducing The Risk Of Cerebrovascular Event In Patients With Fabry Disease	AMICUS THERAPEUTICS	Aug 13, 2025
EP3226841	Anticancer Compositions	ARAGON PHARMACEUTICALS	Jul 9, 2025
EP4062916	Methods Of Treating Fabry Patients Having Renal Impairment	AMICUS THERAPEUTICS	Jul 9, 2025
EP4241849	Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab	F HOFFMANN LA ROCHE	Jun 18, 2025

Discover the latest PTAB cases involving Brand Murray Fuller, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Brand Murray Fuller with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Feb 5, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
BRAND MURRAY FULLER	26	-	-	-
AMICUS THERAPEUTICS	-	17	-	-
F HOFFMANN LA ROCHE	16	146	-	-
NOVARTIS	6	424	-	21